FDA approval is still pending for a new diabetes drug called Galvus that's supposed to help the body balance sugar and insulin production. If approved, it will be the second in a new class of drugs -- with the first being Januvia -- approved in the U.S. last October. In this week's 'Dealing with Diabetes' segment, we take a closer look at what sets the new class apart from the rest.
The drug Januvia prevents the breakdown of GLP-1, a hormone that raises insulin production. It also indirectly inhibits the increase of blood-sugar levels. The once-a-day tablet is the first in a new class of drugs -- called DPP-4 inhibitors. Las Vegas endocrinologist, Fred Toffel, says it's especially ideal for treating an early onset of diabetes.
Dr. Toffel says, "Where it's best useful is early in the disease, people who are close to goal, where you just want to get them a bit lower and get lower safely. That's really where I see this niche. And that's a big niche."
With DPP-4 inhibitors, if blood sugar levels are normal, it doesn't do anything at all -- thereby reducing the risk of hypoglycemia or low sugar. Dr. Toffel says it's a safe drug that can be used alone or in combination. But unlike its well-known injectable counterpart, Byetta, Januvia does not appear to promote weight loss.
Dr. Toffel says, "It's not going to help you loose weight, but it's not going to have you gain weight. Also, essentially, very little side-effects."
Newer drugs are often more expensive and this is the case with Januvia. So depending on your coverage, it may or may not be affordable.
Dr. Toffel says,"The most cost-effective medicine for people are medically poor or have type-2 diabetes is diet and exercise. You get that for nothing. And it's by far still the number one treatment for type-2 disease."
Januvia is made by Merck Pharmaceuticals. It's expected to be a major boost for the drug company, after having to scrap their popular osteoarthritis drug, Vioxx.
Wednesday, May 15 2013 4:58 PM EDT2013-05-15 20:58:55 GMT
Actress Angelina Jolie's decision to have a double mastectomy is sparking strong emotions from women over the questions of whether genetic testing for breast cancer is for everyone,.More>>
Actress Angelina Jolie's decision to have a double mastectomy is sparking strong emotions from women over the questions of whether genetic testing for breast cancer is for everyone, and whether women should have breast surgery, even if they don't have cancer.More>>
Thursday, May 2 2013 6:25 PM EDT2013-05-02 22:25:44 GMT
We usually think of women when we talk about breast cancer, but men are affected as wellin fact about 2-thousand men in this country country are diagnosed with breast cancer everyone, and about 400 die from the disease.More>>
Most discussions about breast cancer tend to focus on women, but men are also affected by the disease. Every year, nearly 2,000 men in this country are diagnosed with breast cancer.More>>
Thursday, May 2 2013 3:21 PM EDT2013-05-02 19:21:04 GMT
LAS VEGAS (AP) -- New government data show Nevada has the second-highest suicide rate in the country among people aged 35 to 64, although the rise in the rate was much slower than it was nationally. TheMore>>
New government data show Nevada has the second-highest suicide rate in the country among people aged 35 to 64, although the rise in the rate was much slower than it was nationally.More>>
Wednesday kicks off American Stroke Month, and medical professionals want people to recognize the warning signs of strokes. Two doctors and stroke experts discussed the dangers on 8 News NOW This Morning.